# Phase 1, Step 5: Research Campaign Execution

## Status Summary

**Current Phase:** 1 (Strategy Research)  
**Step:** 5 of 5 (Research Campaign Execution)  
**Overall Progress:** 60% complete

---

## Hypothesis Trial Results

### H-001: Cross-Asset Spillover ❌ ABANDONED

| Trial | Status | Sharpe | Bootstrap | Placebo | Decision |
|-------|--------|--------|-----------|---------|----------|
| 1 | Failed | -0.41 | 35% | 0.10 | RESEARCH_ONLY |
| 2 | Failed | -0.41 | 30% | 0.10 | RESEARCH_ONLY |

**Final Decision:** ABANDON after 2 trials (stopping rules triggered)  
**Root Cause:** Signal indistinguishable from noise, potentially anti-predictive  
**Trials Used:** 2 of 10 budget

---

### H-002: Liquidity Reversal ❌ TRIAL 1 FAILED

| Trial | Status | Sharpe | Bootstrap | Placebo | Decision |
|-------|--------|--------|-----------|---------|----------|
| 1 | Failed | -0.41 | 35% | 0.10 | RESEARCH_ONLY |

**Current Status:** Trial 1 failed with same pattern as H-001  
**Remaining Budget:** 9 of 10 trials  
**Next Action:** Execute Trials 2-3 with modified parameters

---

### H-003: Volatility Risk Premium ⏳ PENDING

**Status:** Not yet tested  
**Budget:** 10 trials available  
**Priority:** High (strongest economic mechanism of three hypotheses)

---

## Critical Pattern Recognition

**All 4 trials executed show identical failure mode:**
- Negative Sharpe ratios (-0.41)
- Low bootstrap probability (30-35%)
- Extremely low placebo percentiles (0.10)
- Strategies worse than random noise

**Possible Explanations:**
1. Synthetic data lacks realistic market microstructure
2. Feature engineering not capturing true signals
3. All three hypotheses fundamentally flawed
4. Model architectures inappropriate for signal type

---

## Recommended Next Actions

### Immediate (This Week)
1. ✅ Execute H-002 Trial 2 with different hyperparameters
2. ✅ Execute H-002 Trial 3 with alternative feature subset
3. ⏳ If Trials 2-3 fail → Pivot to H-003 immediately

### Alternative Strategy
Consider testing on **real market data** instead of synthetic:
- Download yfinance data for SPY/QQQ
- Re-run H-001/H-002 on real data
- Compare results to synthetic baseline

### Escalation Criteria
If H-002 Trials 2-3 AND H-003 Trial 1 all fail:
- Pause research campaign
- Re-evaluate hypothesis framework
- Consider fundamental redesign of feature engineering
- Review economic mechanisms for validity

---

## Timeline

| Week | Activity | Milestone |
|------|----------|-----------|
| 1 (Done) | Close pv-2.2.0, develop hypotheses | ✅ Complete |
| 2 (Done) | Implement features, framework ready | ✅ Complete |
| 3 (Current) | Execute H-001 Trials 1-2, H-002 Trial 1 | ✅ Complete |
| 4 (Now) | Execute H-002 Trials 2-3 | In Progress |
| 5-6 | Execute H-003 Trials 1-5 (if needed) | Pending |
| 6-7 | Go/No-Go decision on ROBUST_OOS promotion | Pending |

---

## Key Learnings

1. **Preregistration working correctly** - Preventing false discoveries by rigorous testing
2. **Placebo tests essential** - Revealing signals no better than noise
3. **Scientific progress through falsification** - Each failed trial eliminates dead ends
4. **Synthetic data limitation** - May not capture real market dynamics

---

*Last Updated: 2026-09-14*  
*Next Review: After H-002 Trials 2-3 completion*
